CompletedPhase 2

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

NCT01293669

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Clopton Clinic

Jonesboro, Arkansas, United States

+17 additional locations

Save this trial

Clopton ClinicJonesboro, Arkansas, United States
NCA Medical CenterMountain Home, Arkansas, United States
Associated Pharmaceutical Research CenterBuena Park, California, United States
Cedar Crosse Research CenterChicago, Illinois, United States
Medex Healthcare Research, IncSt Louis, Missouri, United States
Om MedicalHenderson, Nevada, United States
MEDEX Healthcare Research, IncNew York, New York, United States
PMG Research of WSWinston-Salem, North Carolina, United States
Rapid Medical Research, Inc.Cleveland, Ohio, United States
Providence Health Partners - Center for ResearchDayton, Ohio, United States
Omega Medical ResearchWarwick, Rhode Island, United States
Ellipsis ResearchColumbia, South Carolina, United States
PMG Research of CharlestonMt. Pleasant, South Carolina, United States
New Phase Research and DevelopmentKnoxville, Tennessee, United States
Mercury Clinical ResearchHouston, Texas, United States
Quality Research, Inc.San Antonio, Texas, United States
Highland Clinical ResearchSalt Lake City, Utah, United States
Strelitz Diabetes Center, Eastern Virginia Medical SchoolNorfolk, Virginia, United States